ADBE enters the final stretch before its June 11 earnings with shorts rebuilding sharply and the analyst community growing more cautious — a combination that sharpens the stock's setup even as the price holds near $243.
The most striking move this week is in short positioning. Short interest climbed roughly 21% over the week, jumping from around 12.3 million shares to nearly 14.9 million, pushing the SI % of free float to 3.6%. The bulk of that move came in a single session — shares short surged on April 23-24, the largest single-week build in the dataset. That said, the absolute level is not extreme. Borrowing costs remain very cheap at 0.31%, and the lending market is loose, with availability well above levels that would signal a constrained borrow pool. The week's short build looks more like a deliberate new position than a squeeze-driven scramble.
Options positioning adds a modest supporting signal. The put/call ratio has edged up to 0.69, running slightly above its 20-day average of 0.67 — about 1.2 standard deviations above the mean. That's a muted reading compared to ADBE's 52-week PCR high of 1.11, but it does show a small tilt toward protection over the past two weeks, consistent with shorts adding exposure rather than options traders panic-hedging.
The Street sent mixed signals this week. Mizuho's Gregg Moskowitz moved to Neutral from Outperform on April 27, cutting his target to $270 from $315 — making it one of the freshest and most directionally significant analyst actions on the name. UBS trimmed its Neutral target from $290 to $260 earlier in April, and Goldman's Sell rating carries a $220 target, the most bearish on the board. The counterweight is RBC Capital, which held its Outperform and $350 target even after trimming from $400 earlier in the month. The mean price target of $328 sits 35% above the current price — but with consensus at Hold and the balance of recent moves pointing lower, the Street is less enthusiastic about closing that gap than the raw numbers suggest. The bear case centers on AI competitive pressure, CEO transition uncertainty, and unclear near-term guidance; bulls point to double-digit revenue growth across key segments and strong monetization discipline. Valuation multiples are undemanding on an EV/EBITDA basis at 7.8x, though the EV/EBIT factor ranks in the 80th percentile — a quality signal the bulls can cite.
Insider activity is unremarkable. The CFO sold a modest $331,000 on April 20, alongside routine award-related sales from other executives on April 15. Net insider activity over 90 days is marginally positive at roughly $1.9 million, driven more by award grants than open-market conviction buying. The passive institutional picture is stable — Vanguard and BlackRock each hold just over 10% and added modestly in Q1.
The earnings reaction history is worth noting as June 11 approaches. The March 12 print was punishing — the stock fell 8.9% the next day and extended losses to 10.1% over the following week after disappointing results. The April 15 announcement reversed that sharply, gaining 5.3% on the day and 8.6% over five days, though that appears to have reflected a guidance update or pre-release rather than a full quarterly print. The pattern underscores that ADBE moves meaningfully around reporting events. With the short score ticking up to 34.8 over the past week after holding near 33 for most of April, the week ahead will test whether the new short interest is anchored in fundamental conviction or simply a tactical trade ahead of the June print.
See the live data behind this article on ORTEX.
Open ADBE on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
